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Effect of Energy Metabolism on NF-kB activity in Ovarian Cancer
Simren Bagri
Department of Biochemistry and Molecular Biology, VCU Massey Cancer Center, Virginia Commonwealth University

Abstract

Results

NF-kB is a transcription factor involved in cancer cell growth and survival.
The activation of NF-kB can be assessed by monitoring phosphorylation of
RelA p65 at Ser-536, which is a surrogate of the NF-kB transcription factor
activation. The objective of this study was to determine if the loss of ATP
leads to NF-kB deficiency and thus, apoptotic cell death of “bad” cells in
ovarian cancer cells. The independent variables were metformin (Met), an
anti-diabetic medicine, another compound MinB functionally similar to Met
and a glucose transporter inhibitor BAY-876. The dependent variables were
the resulting effect of Met and MinB on phosphorylated AMPK at Thr-172
(marker of ATP loss) and RelA p65 ar Ser-536 (marker of NF-kB
activation). In each experiment, AMPK and RelA phosphorylation were
tested by treatment of ovarian cancer cell lines with Met, MinB, BAY-876,
Met+BAY-876, MinB+BAY-876. Western blotting was performed to
determine the phosphorylation levels of AMPK and RelA p65. For two
gels, the process was repeated. In each gel, Met or MinB treatment leads to
thicker bands of AMPK-p, indicating decrease in cellular ATP levels
following treatments. The effect of Met, MinB, or BAY-876 on RelA p65
was limited. However, co-treatment of Met or MinB with BAY-876 caused
strong inhibition of NF-kB, as reflected by reduction in RelA p65-p. These
results suggested that ATP deficiency together with inhibition of glucose
transport cause inactivation of NK-kB.

In both ovarian cancer cell lines in all four gels, ATP deficiency plus
inhibition of glucose transport lead to a significant decrease in band
size. In figures 1 and 2, Metformin and MinB treatment lead to thicker
bands of AMPK-p. There wasn’t a significant change in band size
when Met, MinB, or BAY-876 was tested on RelA p65. Co-treatment
of Met or MinB with Bay-876 showed the thickest bands compared to
all other treated bands in figure 1. In figure 2, co-treatment of Met or
MinB with BAY-876 showed a significant decrease in band size.

Methods
• The research design of this study was experimental as it studied the
relationship between ATP production and NF-kB activity.
• Sodium dodecyl sulfate (SDS) was used to denature the protein
and provide equal mass to charge ratio so as to allow the protein to
move constantly through the gel based on its molecular weight.
The SDS caused proteins to denature and separate from each other
(excluding covalent cross-linking). SDS gel was prepared by first
preparing resolving gel and placing that gel into the prepared glass
ware. The gel solutions ordered were from National Diagnostics in
Atlanta, Georgia. Once membranes were labeled, a black sponge
was placed on top of the white paper which is on top of the gel and
then the apparatus was closed. Approximately 92 volts was run
through the membrane overnight. In the morning, the membranes
were placed in primary and then secondary antibodies. All
antibodies were ordered from Cell Signaling Technology located in
Danvers, MA. For the last step, the membranes were put in a white
carrier. The last step is called luminescence. During this step, an
ECL reaction takes place in which light induces the signal in a
Amersham Hyperfilm film (BioRid, Plymouth, MI). The signal is
both light and time sensitive so too much signal will have a
negative effect on the data sample collected. Running of the gel
was performed on medical film processor SRX-101A (Konica
Minolta Medical & Graphic Inc., Wayne, NJ.) The film was then
analyzed.

Figure 3. Ovarian Cancer

Discussion
• The purpose of this experiment was to see the effect of ATP on
NF-kB activity by performing western blotting.
• It was suggested that the decrease in the amount of ATP is shown
by the thickening of bands on AMP activated protein kinase at
Thr-172. The decrease in ATP results in less apoptosis.
• The thinning of bands in figure 2 by the co-treatment of BAY876 with MinB and Met indicated strong inhibition of NF-kB.
By inhibiting the amount of glucose transport, the cell isn’t able
to get the proper nutrients it needs.
• To summarize, metformin and the metformin like compound had
a significant effect on AMPK-p in the two different cell lines.
Furthermore, this experiment successfully made use of the
symbolic relationship between ATP production and NF-kB.
• When there is ATP deficiency and inhibition of glucose
transport, there is an inactivation of NF-kB.
• In regards to the society, a decrease in the amount of ATP,
through the symbiotic mechanism between decreased
phosphorylated sites on transcription factor and more apoptosis,
offers a more palatable way for individuals looking to reduce the
number of cancer “bad” cells.
• When future researchers open up to testing different cancer cell
lines with different drugs with this same mechanism, there are
high hopes that humans and perhaps other species as well, can
benefit. Future research can be conducted to measure cytokine
production with ELISA assay.
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